Changes in CD4+CD25+ Tregs in the pathogenesis of atherosclerosis in ApoE-/- mice

Li Xue-Mei1, Chen Jie1, Dai Xuan1

  • 1Department of Emergency, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.

Insights

Regulatory T cells (Tregs) depletion is linked to atherosclerosis progression in ApoE knockout mice. This study highlights the anti-atherosclerotic role of Tregs, crucial for understanding disease pathology.

Area of Science:

  • Immunology
  • Cardiovascular Biology
  • Pathology

Background:

  • Atherosclerosis (AS) is a chronic inflammatory disease characterized by plaque buildup in arteries.
  • Regulatory T cells (Tregs) play a critical role in maintaining immune homeostasis and suppressing excessive inflammation.
  • The specific role of Tregs in the development and progression of atherosclerosis requires further elucidation.

Purpose of the Study:

  • To investigate the pathological characteristics of atherosclerotic plaques in ApoE knockout mice.
  • To examine the changes in CD4+CD25+ regulatory T cells (Tregs) in the context of atherosclerosis.
  • To determine the correlation between Treg levels and the severity of atherosclerotic lesions.

Main Methods:

  • Utilized ApoE knockout mice on high-fat (AH) and normal (AN) diets, with C57BL/6J mice as controls (BN).
  • Assessed serum IL-10 and TGF-β1 concentrations via ELISA.
  • Analyzed aortic plaque morphology using H&E staining and morphometry.
  • Examined elastic fiber distribution with Verhoeff stain and identified Foxp3+ cells via immunohistochemistry.
  • Quantified splenic CD4+CD25+ Tregs using flow cytometry.

Main Results:

  • Atherosclerotic plaque development (intima thickness, plaque area) was significantly increased in AN and AH groups compared to BN controls.
  • High-fat diet exacerbated plaque progression in AH mice compared to AN mice.
  • Serum IL-10, TGF-β1 levels, and splenic Treg percentages were significantly decreased in both AN and AH groups compared to controls.
  • Treg levels further decreased in the AH group compared to the AN group.
  • Reduced proportions of Foxp3+ and CD25+ cells were observed in AH mice.

Conclusions:

  • Atherosclerosis in this experimental model is associated with Treg depletion in lymphoid tissues and plaques.
  • CD4+CD25+ Tregs demonstrate a significant anti-atherosclerotic role.
  • Treg dysfunction contributes to the pathogenesis of atherosclerosis, suggesting potential therapeutic targets.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.7K
Inflammation01:38

Inflammation

Overview
63.3K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.0K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
540